These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8575032)

  • 41. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists.
    Turconi M; Nicola M; Quintero MG; Maiocchi L; Micheletti R; Giraldo E; Donetti A
    J Med Chem; 1990 Aug; 33(8):2101-8. PubMed ID: 1695682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.
    van Wijngaarden I; Hamminga D; van Hes R; Standaar PJ; Tipker J; Tulp MT; Mol F; Olivier B; de Jonge A
    J Med Chem; 1993 Nov; 36(23):3693-9. PubMed ID: 8246239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5-Hydroxytryptamine (5-HT3) receptor antagonists. 2. 1-Indolinecarboxamides.
    Bermudez J; Dabbs S; Joiner KA; King FD
    J Med Chem; 1990 Jul; 33(7):1929-32. PubMed ID: 2362271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effect of ethanol on the 5-hydroxytryptamine-induced Bezold-Jarisch reflex--involvement of peripheral 5-HT3 receptors.
    Malinowska B; Göthert M; Godlewski G; Wróbel B; Bönisch H; Buczko W
    Eur J Pharmacol; 1995 May; 293(1):71-6. PubMed ID: 7672010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
    Cunningham RS
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.
    Kishibayashi N; Miwa Y; Hayashi H; Ishii A; Ichikawa S; Nonaka H; Yokoyama T; Suzuki F
    J Med Chem; 1993 Oct; 36(22):3286-92. PubMed ID: 8230119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological properties of KF18259, a novel 5-HT3-receptor antagonist, in rats: inhibition of the distal colonic function.
    Kishibayashi N; Ichikawa S; Yokoyama T; Ishii A; Karasawa A
    Jpn J Pharmacol; 1993 Dec; 63(4):495-502. PubMed ID: 8121082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New 5-HT3 (serotonin-3) receptor antagonists. I. Synthesis and structure-activity relationships of pyrido[1,2-a]indoles.
    Kato M; Ito K; Nishino S; Yamakuni H; Takasugi H
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2546-55. PubMed ID: 7697771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
    J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives.
    Bermudez J; Fake CS; Joiner GF; Joiner KA; King FD; Miner WD; Sanger GJ
    J Med Chem; 1990 Jul; 33(7):1924-9. PubMed ID: 2362270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of serotonin3 receptors in the nucleus tractus solitarii on the carotid chemoreflex.
    Sévoz C; Callera JC; Machado BH; Hamon M; Laguzzi R
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1250-9. PubMed ID: 9087599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel 5-HT3 antagonists. Indole oxadiazoles.
    Swain CJ; Baker R; Kneen C; Moseley J; Saunders J; Seward EM; Stevenson G; Beer M; Stanton J; Watling K
    J Med Chem; 1991 Jan; 34(1):140-51. PubMed ID: 1992112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY; Choi JI; Yoon MH
    Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new 5-HT3 receptor ligand. II. Structure-activity analysis of 5-HT3 receptor agonist action in the gut.
    Yamada M; Sato Y; Kobayashi K; Konno F; Soneda T; Watanabe T
    Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):445-51. PubMed ID: 9549886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
    Levine ME; Chillas JC; Stern RM; Knox GW
    Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and pharmacological characterization of a new benzoxazole derivative as a potent 5-HT3 receptor agonist.
    López-Tudanca PL; Labeaga L; Innerárity A; Alonso-Cires L; Tapia I; Mosquera R; Orjales A
    Bioorg Med Chem; 2003 Jul; 11(13):2709-14. PubMed ID: 12788344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoglossal nerve response to 5-HT3 drugs injected into the XII nucleus and vena cava in the rat.
    Fenik P; Ogawa H; Veasey SC
    Sleep; 2001 Dec; 24(8):871-8. PubMed ID: 11766156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.